Clinicopathologic Significance of BRAF Mutation and Extracellular Signal Regulated Kinase 1/2 Expression in Patients With a Colorectal Adenocarcinoma
Hyung Ook Kim, Beom Gyu Kim, Seong Jae Cha, Yong Gum Park, Tae Jin Lee
Ann Coloproctol. 2015;31(1):9-15.   Published online 2015 Feb 28     DOI: https://doi.org/10.3393/ac.2015.31.1.9
Citations to this article as recorded by Crossref logo
BRAF protein immunoprecipitation, elution, and digestion from cell extract using a microfluidic mixer for mutant BRAF protein quantification by mass spectrometry
Yen-Heng Lin, Heng-Yun Chang, Chia-Chun Wu, Chia-Wei Wu, Kai-Ping Chang, Jau-Song Yu
Analytical and Bioanalytical Chemistry.2019; 411(5): 1085.     CrossRef
Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer
Yinying Wu, Yi Li, Xiaoai Zhao, Danfeng Dong, Chunhui Tang, Enxiao Li, Qianqian Geng
Oncology Letters.2017; 13(1): 129.     CrossRef
Progression inference for somatic mutations in cancer
Leif E. Peterson, Tatiana Kovyrshina
Heliyon.2017; 3(4): e00277.     CrossRef
DoesBRAFMutation and Extracellular Signal Regulated Kinase Expression in Patients With Colorectal Cancer Have Any Prognostic Significance?
Moo Jun Baek
Annals of Coloproctology.2015; 31(1): 1.     CrossRef